<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: ORBIMED ADVISORS LLC -->
          <cik>0001055951</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001787297</issuerCik>
      <issuerName>Passage BIO, Inc.</issuerName>
      <secFileNumber>001-39231</secFileNumber>
      <issuerAddress>
        <com:street1>One Commerce Square</com:street1>
        <com:street2>2005 Market Street, 39th Floor</com:street2>
        <com:city>Philadelphia</com:city>
        <com:stateOrCountry>PA</com:stateOrCountry>
        <com:zipCode>19103</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>267-866-0312</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>OrbiMed Private Investments VII, LP</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Themis Trading LLC</name>
        <address>
          <com:street1>10 Town Square</com:street1>
          <com:street2>Suite 100</com:street2>
          <com:city>Chatham</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>07928</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>132645</noOfUnitsSold>
      <aggregateMarketValue>737506.20</aggregateMarketValue>
      <noOfUnitsOutstanding>3120295</noOfUnitsOutstanding>
      <approxSaleDate>07/21/2025</approxSaleDate>
      <securitiesExchangeName>Nasdaq Stock Market</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>03/03/2020</acquiredDate>
      <natureOfAcquisitionTransaction>IPO</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>132645</amountOfSecuritiesAcquired>
      <paymentDate>03/03/2020</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>04/22/2025</saleDate>
      <amountOfSecuritiesSold>78049</amountOfSecuritiesSold>
      <grossProceeds>26537.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>04/23/2025</saleDate>
      <amountOfSecuritiesSold>89328</amountOfSecuritiesSold>
      <grossProceeds>30372.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>04/24/2025</saleDate>
      <amountOfSecuritiesSold>68195</amountOfSecuritiesSold>
      <grossProceeds>21822.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>06/24/2025</saleDate>
      <amountOfSecuritiesSold>231600</amountOfSecuritiesSold>
      <grossProceeds>81060.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>06/25/2025</saleDate>
      <amountOfSecuritiesSold>138800</amountOfSecuritiesSold>
      <grossProceeds>45804.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>06/26/2025</saleDate>
      <amountOfSecuritiesSold>213257</amountOfSecuritiesSold>
      <grossProceeds>70374.81</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>06/27/2025</saleDate>
      <amountOfSecuritiesSold>11043</amountOfSecuritiesSold>
      <grossProceeds>3754.62</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>07/07/2025</saleDate>
      <amountOfSecuritiesSold>23960</amountOfSecuritiesSold>
      <grossProceeds>11500.80</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>07/08/2025</saleDate>
      <amountOfSecuritiesSold>50700</amountOfSecuritiesSold>
      <grossProceeds>21801.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>07/09/2025</saleDate>
      <amountOfSecuritiesSold>57106</amountOfSecuritiesSold>
      <grossProceeds>25126.64</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>07/10/2025</saleDate>
      <amountOfSecuritiesSold>127234</amountOfSecuritiesSold>
      <grossProceeds>50893.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>07/15/2025</saleDate>
      <amountOfSecuritiesSold>3700</amountOfSecuritiesSold>
      <grossProceeds>25049.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>07/16/2025</saleDate>
      <amountOfSecuritiesSold>20048</amountOfSecuritiesSold>
      <grossProceeds>117481.28</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>07/17/2025</saleDate>
      <amountOfSecuritiesSold>22188</amountOfSecuritiesSold>
      <grossProceeds>129356.04</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>OrbiMed Private Investments VII, LP</name>
        <address>
          <com:street1>601 Lexington Ave., 54th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>07/18/2025</saleDate>
      <amountOfSecuritiesSold>7357</amountOfSecuritiesSold>
      <grossProceeds>41934.90</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>OrbiMed Capital GP VII LLC is the general partner of OrbiMed Private Investments VII, LP. OrbiMed Advisors LLC is the managing member of OrbiMed Capital GP VII LLC. All sales of securities listed on this Form 144 made prior to July 14, 2025 reflect share amounts prior to the 1-for-20 reverse stock split that was effectuated by the Issuer on July 14, 2025.</remarks>
    <noticeSignature>
      <noticeDate>07/21/2025</noticeDate>
      <signature>/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors LLC, managing member of the general partner of OrbiMed Private Investments VII, LP</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
